Our RNA-Seq data indicate that bronchial ECM from COPD patients may contribute to dysregulated signaling along the PDGF-BB/ERK2 axis, which could reflect processes of vascular remodeling in COPD patients. The gene discussed is MAPK1; the disease is chronic obstructive pulmonary disease.